Active	Status	Sponsor type	Region	Phase	Filter
5 Active 5 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhang, Ling
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis	Recruiting	3	368	Europe, US, RoW	SHR0302, Placebo	Reistone Biopharma Company Limited, Reistone Biopharma Company Limited	Ulcerative Colitis	10/24	03/25
NCT06081920: A Study of IBI363 in Subjects With Advanced Melanoma	Recruiting	2	120	RoW	IBI363	Innovent Biologics (Suzhou) Co. Ltd.	Melanoma	06/25	07/26